Matthijs M Jore - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matthijs M Jore

Showing results (41-50 of 50) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 50 results.

Science Advances|November 7, 2025

Pfs230 domain 12 is a potent malaria transmission-blocking vaccine candidateMaartje R Inklaar, Roos M de Jong, Dari F Da, et al.

Nature Structural & Molecular Biology|April 5, 2011

Structural basis for CRISPR RNA-guided DNA recognition by CascadeMatthijs M Jore, Magnus Lundgren, Esther van Duijn, et al.

Immunity|October 10, 2025

Cryo-EM structure of endogenous Pfs230:Pfs48/45 complex with six antibodies reveals mechanisms of malaria transmission-blocking activityEzra T Bekkering, Randy Yoo, Sophia Hailemariam, et al.

Immunity|February 15, 2023

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230Danton Ivanochko, Amanda Fabra-García, Karina Teelen, et al.

The Lancet. Infectious Diseases|August 13, 2022

Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adultsSaskia C van der Boor, Merel J Smit, Stijn W van Beek, et al.

Immunity|August 17, 2022

Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.

Immunity|February 15, 2023

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoesAmanda Fabra-García, Sophia Hailemariam, Roos M de Jong, et al.

Science Translational Medicine|June 7, 2019

Naturally acquired immunity against immature <i>Plasmodium falciparum</i> gametocytesKathleen W Dantzler, Siyuan Ma, Priscilla Ngotho, et al.

Nature Communications|February 10, 2018

Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.

Nature Communications|April 13, 2018

Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.

Pageof 5

Search research articles

Showing results (41-50 of 50) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 50 results.

Science Advances|November 7, 2025

Pfs230 domain 12 is a potent malaria transmission-blocking vaccine candidateMaartje R Inklaar, Roos M de Jong, Dari F Da, et al.

Nature Structural & Molecular Biology|April 5, 2011

Structural basis for CRISPR RNA-guided DNA recognition by CascadeMatthijs M Jore, Magnus Lundgren, Esther van Duijn, et al.

Immunity|October 10, 2025

Cryo-EM structure of endogenous Pfs230:Pfs48/45 complex with six antibodies reveals mechanisms of malaria transmission-blocking activityEzra T Bekkering, Randy Yoo, Sophia Hailemariam, et al.

Immunity|February 15, 2023

The Lancet. Infectious Diseases|August 13, 2022

Immunity|August 17, 2022

Immunity|February 15, 2023

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoesAmanda Fabra-García, Sophia Hailemariam, Roos M de Jong, et al.

Science Translational Medicine|June 7, 2019

Naturally acquired immunity against immature <i>Plasmodium falciparum</i> gametocytesKathleen W Dantzler, Siyuan Ma, Priscilla Ngotho, et al.

Nature Communications|February 10, 2018

Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.

Nature Communications|April 13, 2018

Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.

Pageof 5